ANIX (Anixa Biosciences) Buyback Yield %: -5.04 (As of Jul. 01, 2026)


ANIX Anixa Biosciences Inc ANIX
27 GF Score
Price $2.85
! 3 Warning Signs
View Full Analysis

What is Anixa Biosciences Buyback Yield %?

Anixa Biosciences ANIX +1.79% 27 Buyback Yield % is -5.04 as of Jul. 01, 2026. GuruFocus rates ANIX with a GF Score™ of 27/100. The stock has 3 warning signs investors should review. Among 745 Biotechnology companies, Anixa Biosciences ranks better than 59.33% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Anixa Biosciences's current buyback yield was -5.04%.

Anixa Biosciences Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Anixa Biosciences's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anixa Biosciences Buyback Yield % Chart

Anixa Biosciences Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.71 0.00 0.00 -2.62 -1.74

Anixa Biosciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 -1.91 -1.74 -3.51 -4.71

ANIX vs BMEA, PMN, ATRA: Buyback Yield % Comparison

For the Biotechnology subindustry, Anixa Biosciences's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anixa Biosciences Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anixa Biosciences's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Anixa Biosciences's Buyback Yield % falls into.


ANIX
27GF Score
Anixa Biosciences Inc ANIX
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anixa Biosciences Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Anixa Biosciences's Buyback Yield for the fiscal year that ended in Oct. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 2.378) / 136.34782
=-1.74%

Anixa Biosciences's annualized Buyback Yield for the quarter that ended in Apr. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (4.797 + 0) / 101.769
=-4.71%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -5.04 mean?
Anixa Biosciences (ANIX) has a Buyback Yield % of -5.04 as of Jul. 01, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Anixa Biosciences and its competitors. According to the industry distribution chart, Anixa Biosciences ranks #303 out of 745 companies in the Biotechnology industry, placing it in the top 40.7%.
Is Anixa Biosciences' Buyback Yield % too high?
Anixa Biosciences' current Buyback Yield % is -5.04. Based on the distribution chart, Anixa Biosciences ranks #303 out of 745 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Anixa Biosciences has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Anixa Biosciences' Buyback Yield % compare to BMEA and PMN?
According to the Biotechnology industry distribution chart, Anixa Biosciences ranks #303 out of 745 companies for Buyback Yield %. This puts Anixa Biosciences in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Anixa Biosciences and its competitors. Anixa Biosciences's current Buyback Yield % is -5.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anixa Biosciences stock overvalued right now?
Anixa Biosciences (ANIX) has a current Buyback Yield % of -5.04. The current Buyback Yield % is -5.04. Anixa Biosciences' overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Anixa Biosciences (ANIX), the current Buyback Yield % is -5.04 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anixa Biosciences Business Description

Other Exchanges CY71:Germany
Address 3150 Almaden Expressway, Suite 250, San Jose, CA, USA, 95118
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
27GF Score

Get the complete analysis for ANIX

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.85
Price